Merck & Co., Inc. (MRK) announced the European Commission, or EC, approval of ELONVA, or corifollitropin alfa injection. ELONVA is indicated for controlled ovarian stimulation in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology program. ELONVA is the first sustained follicle stimulant.
With the EC approval, Merck receives marketing authorization for ELONVA with unified labeling valid in all European Union Member States.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.